SEC Comment Letter 0000000000-24-009645 to ORAGENICS INC (OGEN)
ORAGENICS INC
Date: Aug. 23, 2024 · CIK: 0001174940 · Accession: 0000000000-24-009645
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281618
Letter
August 23, 2024 J. Michael Redmond President and Interim Principal Executive Officer Oragenics Inc. 1990 Main Street, Suite 750 Sarasota, Florida 34236 Re:Oragenics Inc. Registration Statement on Form S-1 Filed August 16, 2024 File No. 333-281618 Dear J. Michael Redmond: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Mark Catchur
Show Raw Text
August 23, 2024
J. Michael Redmond
President and Interim Principal Executive Officer
Oragenics Inc.
1990 Main Street, Suite 750
Sarasota, Florida 34236
Re:Oragenics Inc.
Registration Statement on Form S-1
Filed August 16, 2024
File No. 333-281618
Dear J. Michael Redmond:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Mark Catchur